RADIOACTIVITY.EU.COM

icon THE PHENOMENON

THE PHENOMENON

icon IN DAILY LIFE

IN DAILY LIFE

icon QUESTION OF DOSES

QUESTION OF DOSES

icon AT THE DOCTOR’S

AT THE DOCTOR’S

icon At the laboratory

At the laboratory

icon At the museum

At the museum

icon NUCLEAR ENERGY

NUCLEAR ENERGY

icon RADIOACTIVE WASTE

RADIOACTIVE WASTE

The aim of this web site is to explain radioactivity and its applications to the general public.

icon Dose Rate

Dose Rate

Acute and chronic exposures

Influence of the dose rates on mices cancers
Decreasing the dose rate, by spreading an intensive dose on a rather long time reduces the risk. Quantitative data are available only for animals, like this comparison of the incidences of cancers on mices between an intense, brief exposures to X or gamma rays and prolonged daily exposures (the total dose is the same). Experience suggests a reduction factor for low rate situated between two and ten. The value of two was used to set acceptable limits for humans.
© IN2P3 (Source IRSN) ©

The “effective dose” is not sufficient by itself to characterize one exposure to radioactivity. Among the factors to consider, one of the most important is the dose rate that takes into account the duration of exposure.

The exposure to radiation is like the exposure to summer sunrays. Burns of a sunburn result from a short and intense exposure to ultraviolet while skin supports without damaging the same dose received over several hours.

In the case of high doses, there is good reasons to believe that spreading the exposure over time reduces risk. It is likely that cellular repair mechanisms operate at low radiation rates, but are overwhelmed with high rates. This explains the reduced toxicity of low dose rates. However, there are only littlestatistical data in humans on this reduction.

Experiments on animals suggest a reduction factor of between 2 and 10. A better understanding of what happens with humans, would require studies – called epidemiological – on people so-exposed. But cases when high doses rates can be compared to low rates are rare and radioprotection experts stumble again on the impediment of a lack of data in the field.

The influence of dose rate is currently neglected by regulation and legislative texts. For example, the current legislation of radiation protection is based on a linear relationship between the number of cancers and doses. This relationship, itself based on the results of studies on survivors of Hiroshima and Nagasaki, put on the same curve a single and intense exposure whose duration was only a few seconds, as in Hiroshima and Nagasaki or a medical CT-Scan, and chronic exposures, sometimes sparingly issued days after days? This is one of the unsolved problems at the moment.

The International Commission on Radiological Protection (ICRP website) has begun to consider dose rates in its recommendations. A mitigating factor (called DDREF) is now taken into account in the case of gamma rays to reduce the effects of exposure to chronic low dose rate.